MAI Capital Management’s BioNTech BNTX Stock Holding History

MAI Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-158	Closed	-$14K	–	2416
2026 Q1	$14K	Buy	158 +13	+9%	+$1.34K	﹤0.01%	2972
2025 Q4	$13.8K	Hold	145	–	–	﹤0.01%	2703
2025 Q3	$14.3K	Buy	145 +7	+5%	+$748	﹤0.01%	2576
2025 Q2	$14.7K	Buy	138 +3	+2%	+$303	﹤0.01%	2518
2025 Q1	$12.3K	Sell	135 -25	-16%	-$2.8K	﹤0.01%	2406
2024 Q4	$18.2K	Buy	+160	New	+$18.3K	﹤0.01%	2261

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

MAI Capital Management's BNTX Position: Q2 2026 in Review

MAI Capital Management sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 158 shares — an estimated $14K sold.

MAI Capital Management first reported a position in BNTX in Q4 2024 and held it in 6 quarters. The position peaked at $18.2K in Q4 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

MAI Capital Management reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
MAI Capital Management sold 158 BioNTech shares in Q2 2026, an estimated $14K.
MAI Capital Management first reported a position in BioNTech in Q4 2024 and held it in 6 quarters.
MAI Capital Management's BioNTech position peaked at $18.2K in Q4 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.